JP2011126894A5 - - Google Patents

Download PDF

Info

Publication number
JP2011126894A5
JP2011126894A5 JP2011017553A JP2011017553A JP2011126894A5 JP 2011126894 A5 JP2011126894 A5 JP 2011126894A5 JP 2011017553 A JP2011017553 A JP 2011017553A JP 2011017553 A JP2011017553 A JP 2011017553A JP 2011126894 A5 JP2011126894 A5 JP 2011126894A5
Authority
JP
Japan
Prior art keywords
azithromycin
monohydrate
organic solvent
stable
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011017553A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011126894A (ja
Filing date
Publication date
Priority claimed from GBGB9915216.7A external-priority patent/GB9915216D0/en
Priority claimed from GBGB9915218.3A external-priority patent/GB9915218D0/en
Priority claimed from GBGB9930059.2A external-priority patent/GB9930059D0/en
Application filed filed Critical
Publication of JP2011126894A publication Critical patent/JP2011126894A/ja
Publication of JP2011126894A5 publication Critical patent/JP2011126894A5/ja
Pending legal-status Critical Current

Links

JP2011017553A 1999-06-29 2011-01-31 マクロライド Pending JP2011126894A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9915216.7A GB9915216D0 (en) 1999-06-29 1999-06-29 Organic compounds
GB9915216.7 1999-06-29
GB9915218.3 1999-06-29
GBGB9915218.3A GB9915218D0 (en) 1999-06-29 1999-06-29 Organic compounds
GBGB9930059.2A GB9930059D0 (en) 1999-12-20 1999-12-20 Organic compounds
GB9930059.2 1999-12-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001507048A Division JP4703924B2 (ja) 1999-06-29 2000-06-27 マクロライド

Publications (2)

Publication Number Publication Date
JP2011126894A JP2011126894A (ja) 2011-06-30
JP2011126894A5 true JP2011126894A5 (enExample) 2012-03-01

Family

ID=27269768

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001507048A Expired - Fee Related JP4703924B2 (ja) 1999-06-29 2000-06-27 マクロライド
JP2011017553A Pending JP2011126894A (ja) 1999-06-29 2011-01-31 マクロライド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001507048A Expired - Fee Related JP4703924B2 (ja) 1999-06-29 2000-06-27 マクロライド

Country Status (10)

Country Link
US (1) US6703372B1 (enExample)
EP (2) EP1189915B1 (enExample)
JP (2) JP4703924B2 (enExample)
KR (1) KR100700475B1 (enExample)
AT (2) ATE469910T1 (enExample)
AU (1) AU5820400A (enExample)
DE (3) DE60029589T2 (enExample)
ES (2) ES2267549T3 (enExample)
HR (1) HRP20010956B1 (enExample)
WO (1) WO2001000640A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
ATE320441T1 (de) 2000-07-25 2006-04-15 Silanes Sa De Cv Lab Einstufiges verfahren zur herstellung von 7,16-
ES2172417B1 (es) * 2000-07-31 2003-09-16 Sint Quimica Sa Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
CA2429639C (en) * 2000-11-27 2009-07-14 Biochemie S.A. Stable azithromycin monohydrate
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
IL158591A0 (en) * 2001-05-22 2004-05-12 Pfizer Prod Inc Crystal forms of azithromycin
EP1671979B1 (en) * 2001-05-22 2008-08-13 Pfizer Products Inc. New Cristal Form of Azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1455757A2 (en) * 2001-12-21 2004-09-15 Pfizer Products Inc. Methods for wet granulating azithromycin
US20050209446A1 (en) * 2002-02-26 2005-09-22 Meiji Seika Kaisha Ltd. Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these
JP2005522470A (ja) * 2002-04-03 2005-07-28 ハンミ ファーム． シーオー．， エルティーディー． アジスロマイシンの製造方法及びそれに用いられる９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシンＡの結晶性水和物
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
WO2005009447A1 (en) * 2003-07-24 2005-02-03 Pliva - Research And Development Ltd. Single dose fast dissolving azithromycin
US20060189800A1 (en) * 2003-07-24 2006-08-24 Mitsuru Ohkubo Indolopyrrolocabazole derivative and antitumor agent
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
US20080161249A1 (en) * 2004-11-17 2008-07-03 Smithkline Beecham Corporation Use of Novel Antibacterial Compounds
CN101177441B (zh) * 2007-12-05 2012-05-23 浙江耐司康药业有限公司 一种稳定的阿奇霉素一水合物结晶的制备方法
CN101445532B (zh) * 2008-12-30 2011-09-21 广东东阳光药业有限公司 阿奇霉素一水合物结晶的制备方法
US20120058936A1 (en) 2009-03-13 2012-03-08 Assistance Publique - Hopitaux De Paris Compositions and methods for elimination of gram negative bacteria
CN102417531B (zh) * 2011-12-20 2014-06-11 浙江国邦药业有限公司 一种阿奇霉素一水合物的制备方法
CN105030704B (zh) * 2015-06-29 2018-09-07 石药集团欧意药业有限公司 阿奇霉素片剂及其制备方法
CN110684056B (zh) * 2018-07-05 2021-07-13 青岛农业大学 一种阿奇霉素中间体的化学合成方法
CN114516895A (zh) * 2020-11-19 2022-05-20 江苏威奇达药业有限公司 一种阿奇霉素胺结晶方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
GB9705323D0 (en) 1997-03-14 1997-04-30 Biochemie Sa Organic compounds
CN1157402C (zh) * 1997-07-08 2004-07-14 生物化学股份有限公司 有机化合物
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
GB9824580D0 (en) 1998-11-10 1999-01-06 Biochemie Sa Organic compounds

Similar Documents

Publication Publication Date Title
BR112013011593A2 (pt) cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo
MY167395A (en) Method for producing glufosinate p free acid
RU2018106948A (ru) Способ получения замещенных производных 3-(2-анилино-1-циклогексил -1н-бензимидазол-5-ил)пропановой кислоты
WO2014170842A3 (en) Substituted alkyl carboxylic acid derivatives as gpr agonists
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
RU2017123112A (ru) Способ производства кристаллов производного диазабициклооктана и стабильного лиофилизированого препарата
MX2019000031A (es) Procedimientos para la preparación de una solución de levotiroxina.
CO6700138A1 (es) Procedimiento de preparación de sal de l-arginina de perindoprilo
AR084864A1 (es) Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso
RU2016106125A (ru) Соли дасатиниба в кристаллической форме
RU2012105279A (ru) Способ получения кристаллов полиморфной 2-(3-циано-4-изобутилоксифенил)-4-метил-5-тиазолкарбоновой кислоты с добавлением растворителя, плохо растворяющего вещество
RU2014143717A (ru) Кристалл циклопептида высокой чистоты, а также способ его получения и его применение
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
ES2571043T3 (es) Preparación de dihidropiridinas
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
RU2019106531A (ru) Кристалл соли производного хиназолина
JP2013528577A5 (enExample)
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
HK1200458A1 (en) Methods of isolating 4-chloro-2-fluoro-3-substituted-phenylboronic acids
WO2011108009A3 (en) Process for the preparation of fampridine
MX2010007923A (es) Forma cristalina de abacavir que esta esencialmente libre de disolvente.
BRPI0616169B8 (pt) cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina
EA201390016A1 (ru) Способ получения производных пирано[2,3-c]пиридина
BR112023024037A2 (pt) Sal farmaceuticamente aceitável de derivado de pirazoloheteroarila, formas cristalinas, composição farmacêutica, usos dos mesmos e métodos para preparar as referidas formas cristalinas e composição farmacêutica
WO2010079497A3 (en) Novel polymorph of atazanavir sulfate